openPR Logo
Press release

Mesothelioma: The “Orphan” Cancer

10-12-2007 12:55 PM CET | Politics, Law & Society

Press release from: The Law Offices of James Sokolove

Government funding remains elusive for deadly disease

Newton, MA. Oct. 1st 2007. While Americans have long been romanced by campaigns for breast cancer and leukemia research, it may be some time before mesothelioma enjoys a stint in the spotlight. Despite the fact that over 2,500 cases of the disease are diagnosed in the U.S. each year—with as many or more dying from it—the need to develop effective treatments for mesothelioma victims continues to be overlooked by the federal government.

“Even though it has been medically documented since the 1940s, mesothelioma remains very much an ‘orphan’ disease today,” says Attorney Jim Sokolove, principal and founder of the Law Offices of James Sokolove (www.jimsokolove.com). “The government has yet to recognize this disease as the epidemic that it really is.”

Between 2000 and 2003, the National Cancer Institute (NCI) invested less than $2 million annually in clinical research for mesothelioma—a fraction of the funds invested in other types of cancers. And although Congress has allocated $3.75 billion for research on various diseases since 1992, none of this money has been allocated to furthering mesothelioma studies. With no effective treatments available, the disease is almost always fatal, with an average survival time of 12 months following diagnosis.

Sokolove cites complex economic and political factors among the many reasons why mesothelioma has failed to receive significant national funding. "Although enormous financial resources are available to help improve mesothelioma treatment, there is no real effort to commit these resources.”

One group is lobbying aggressively to reverse the rising tide of mesothelioma deaths in the U.S. The Mesothelioma Applied Research Foundation (MARF) coordinates numerous efforts to advance funding, studies and treatment for the disease. In 2005, MARF succeeded in obtaining from Congress the first appropriation ever for mesothelioma research.

The Law Offices of James Sokolove worked closely with MARF in the development of its new website, the Mesothelioma Resource Center (www.mesorc.com), a comprehensive support and information resource for mesothelioma victims and their families.

“MARF is doing extraordinary things in getting the voice of the mesothelioma community to be heard,” Sokolove remarks. “Through the Mesothelioma Resource Center, the LOJS hopes to compliment their efforts and provide much-needed support to victims and their loved ones.”

Those interested in learning more about mesothelioma research, clinical trials, and treatments can register for free updates at www.mesorc.com. For each person that signs up, the Law Offices of James Sokolove will make a $200 donation to MARF.

The Law Offices of James Sokolove
1340 Centre St # 102, Newton Center,
Massachusetts MA 02459
Phone: 617-742-0696 Ext 413
Fax: 617-964-4336

About The Law Offices of James Sokolove

The Law Offices of James Sokolove (LOJS) is the nation’s largest and fastest growing marketer of legal services, providing qualified law firms, with the most cost efficient and highly qualified case leads. For over 30 years, the LOJS has endeavored to reinvent how people obtain legal services, in order to provide everyone, irrespective of ethnicity or income, equal access to our civil justice system and within it, superior quality of representation and service. Working with an affiliate network of over 300 law firm throughout the US, the LOJS generates over 200,000 leads and 12,000 signed cases annually, translating into over one quarter billion in revenue dollars for its affiliates. As the legal profession continues to experience unprecedented and dynamic change, the LOJS business model is a proven success as it strategically matches specific client needs with particular law firm expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mesothelioma: The “Orphan” Cancer here

News-ID: 30266 • Views: 2158

More Releases from The Law Offices of James Sokolove

THE LAW OFFICES OF JAMES SOKOLOVE CONTNUES ADDITIONS TO MESOTHELIOMA RESOURCE CE …
The Law Offices of James Sokolove (LOJS), dedicated to providing greater access to the civil justice system, introduced more features to the ground-breaking community site, Mesothelioma Resource Center (MesoRC) to include a Community Marketplace and a Tribute Wall. The MesoRC website also provides a powerful one-stop informational resource for victims and families affected by this rare and aggressive cancer. Since its launch in September 2007, the site has seen continuing
The Law Offices of James Sokolove Adds CFO
The Law Offices of James Sokolove (LOJS), a company dedicated to reinventing how people access to the civil justice system, today announced the creation of a new executive role with the appointment of Rob Bunn as chief financial officer. After consulting for LOJS since 2004, Rob will now play a central role in developing and evaluating the Company’s financial direction and capital market activities. “Rob’s in-depth knowledge of LOJS and
THE LAW OFFICES OF JAMES SOKOLOVE WARNS CONSUMERS OF BIRTH CONTROL RING DANGERS
The Law Offices of James Sokolove (LOJS), dedicated to providing equal access to the civil justice system, conveyed its deep concerns at reports of deadly side effects linked to the hormonal contraceptive ring device, NuvaRing. Used by 1.5 million women worldwide, the device has been associated with a significantly increased risk of blood clots, strokes, heart attacks, and in extreme cases, death. “Data has been available since 1995 which clearly
The Law Offices of James Sokolove Highlights Trajedy of Trasylol
Newton, Mass., Feb. 21, 2008 − The Law Offices of James Sokolove (LOJS), dedicated to providing equal access to the civil justice system, expressed its continuing dismay following a recent report on the tragedy linked to the drug Trasylol®. According to a recent segment that aired on the CBS program 60 Minutes, the drug’s manufacturer failed to adequately warn doctors and patients of the risks involved in its use resulting

All 5 Releases


More Releases for MARF

Mesothelioma: A Rare Cancer That Needs Funding To Find A Cure
September 22, 2010, Wellesley, MA –On September 26, 2010, Sokolove Law will recognize Mesothelioma Awareness Day, which was inaugurated five years ago by the Mesothelioma Applied Research Foundation (MARF) to bring attention to this deadly, incurable and often overlooked cancer. Activities include regional fundraising events and local government proclamation requests in dozens of states, counties and cities. Most people who suffer from mesothelioma have been exposed on a regular
For Mesothelioma Victims, Knowledge is Power
For people with malignant mesothelioma, a rare and serious cancer caused by asbestos, finding information on their illness can be as challenging as its symptoms. The Law Offices of James Sokolove (www.jimsokolove.com) hopes to change this with the launch of the Mesothelioma Resource Center, a comprehensive online resource designed for mesothelioma victims as well as their caregivers and families. “So many of these individuals already feel alone in their struggle,”